Patents by Inventor Henrik Oster

Henrik Oster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9770444
    Abstract: The present invention relates to a modulator of glucocorticoid biosynthesis, degradation and/or receptor activation for use in preventing or treating symptoms and/or diseases associated with jet lag. The compositions of the invention may be used as a lead compound for developing a drug for preventing or treating symptoms and/or diseases associated with jet lag. The invention relates to the discovery that administration of the modulator(s) to a subject results in a directional change of the time point of maximum amounts of glucocorticoids in the subject as compared to the time point of maximum amounts of glucocorticoids in a subject not treated with the modulator(s).
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: September 26, 2017
    Assignee: MAX-PLANCK-GESELLSCHAFT-ZUR-FĂ–RDERUNG DER WISSENSCHAFTEN E.V
    Inventors: Gregor Eichele, Henrik Oster, Silke Kiessling
  • Publication number: 20150105428
    Abstract: The present invention relates to a modulator of glucocorticoid biosynthesis, degradation and/or receptor activation for use in preventing or treating symptoms and/or diseases associated with jet lag. The compositions of the invention may be used as a lead compound for developing a drug for preventing or treating symptoms and/or diseases associated with jet lag. The invention relates to the discovery that administration of the modulator(s) to a subject results in a directional change of the time point of maximum amounts of glucocorticoids in the subject as compared to the time point of maximum amounts of glucocorticoids in a subject not treated with the modulator(s).
    Type: Application
    Filed: December 17, 2014
    Publication date: April 16, 2015
    Inventors: Gregor Eichele, Henrik Oster, Silke Kiessling
  • Patent number: 8946263
    Abstract: The present invention relates to a modulator of glucocorticoid biosynthesis, degradation and/or receptor activation for use in preventing or treating symptoms and/or diseases associated with jet lag. The compositions of the invention may be used as a lead compound for developing a drug for preventing or treating symptoms and/or diseases associated with jet lag. The invention relates to the discovery that administration of the modulator(s) to a subject results in a directional change of the time point of maximum amounts of glucocorticoids in the subject as compared to the time point of maximum amounts of glucocorticoids in a subject not treated with the modulator(s).
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: February 3, 2015
    Assignee: Max-Planck-Gesellchaft zur Forderung der Wissenschaften E.V.
    Inventors: Gregor Eichele, Henrik Oster, Silke Kiessling
  • Publication number: 20120230978
    Abstract: The present invention relates to a modulator of glucocorticoid biosynthesis, degradation and/or receptor activation for use in preventing or treating symptoms and/or diseases associated with jet lag. The compositions of the invention may be used as a lead compound for developing a drug for preventing or treating symptoms and/or diseases associated with jet lag. The invention relates to the discovery that administration of the modulator(s) to a subject results in a directional change of the time point of maximum amounts of glucocorticoids in the subject as compared to the time point of maximum amounts of glucocorticoids in a subject not treated with the modulator(s).
    Type: Application
    Filed: March 7, 2012
    Publication date: September 13, 2012
    Applicant: Max-Planck-Gesellschaft-zur-Forderung der Wissenschaften e.V.
    Inventors: Gregor Eichele, Henrik Oster, Silke Kiessling